MedPath

Chloroquine Phosphate

Chloroquine Phosphate Tablets, USP

Approved
Approval ID

cc0cb812-48f9-a138-e053-2a95a90a7666

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2024

Manufacturers
FDA

Suven Pharmaceuticals Limited

DUNS: 677604288

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Chloroquine Phosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68022-0265
Application NumberANDA214756
Product Classification
M
Marketing Category
C73584
G
Generic Name
Chloroquine Phosphate
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 9, 2024
FDA Product Classification

INGREDIENTS (1)

CHLOROQUINE PHOSPHATEActive
Quantity: 500 mg in 1 1
Code: 6E17K3343P
Classification: ACTIB

Chloroquine Phosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68022-0264
Application NumberANDA214756
Product Classification
M
Marketing Category
C73584
G
Generic Name
Chloroquine Phosphate
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 9, 2024
FDA Product Classification

INGREDIENTS (1)

CHLOROQUINE PHOSPHATEActive
Quantity: 500 mg in 1 1
Code: 6E17K3343P
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Chloroquine Phosphate - FDA Drug Approval Details